MEDINCELL S.A.
Biotechnology · Healthcare
CEO
1 appearance
Latest appearance 2026-06-16
Christophe Douat
CEO
MEDINCELL S.A.
Equibles does not estimate personal net worth.
About Christophe Douat
Christophe Douat is recorded as CEO at MEDINCELL S.A.. Christophe Douat has spoken on 1 earnings call across 1 company, most recently for MEDINCELL S.A. on June 16, 2026. MEDINCELL S.A. is classified in the Biotechnology industry within the Healthcare sector.
Christophe Douat on recent calls
“Let me start with Made in Sales trajectory. Our shift to growth strategy is built around three engines of growth, all powered by Made in Cells innovation. The first is Risperidone LAI with UZD, successfully marketed in the US since 2023 by our partner Teva.”
Affiliation history
-
MEDINCELL S.A.
CEO
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
Videoconference • Annual results 2025-26
MEDINCELL S.A.